Studies on the teratogenic effects of different oral preparations of caffeine in mice. 1982

M M Elmazar, and P R McElhatton, and F M Sullivan

Caffeine in doses up to 250 mg/kg per day in drinking water or up to 150 mg/kg per day in sustained release pellets was administered to pregnant mice. Apart from a low incidence of cleft palate, in the 50 mg/kg and 150 mg/kg caffeine pellet groups no gross abnormalities were observed which were attributable to caffeine treatment. The most important effect observed was a reduction in fetal weight. Retarded ossification particularly of the supraoccipital bones was observed in fetuses when caffeine (150 mg/kg) was administered in drinking water but not when the same dose was given as a sustained release pellet. Analysis of caffeine blood level data showed that the total exposure from the pellets was greater than from the drinking water. It would thus appear that the effect on the supraoccipital bones is an indirect one mediated through reduced food and water intake of the dams when caffeine is administered in drinking water.

UI MeSH Term Description Entries
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011270 Pregnancy, Animal The process of bearing developing young (EMBRYOS or FETUSES) in utero in non-human mammals, beginning from FERTILIZATION to BIRTH. Animal Pregnancies,Animal Pregnancy,Pregnancies, Animal
D001842 Bone and Bones A specialized CONNECTIVE TISSUE that is the main constituent of the SKELETON. The principal cellular component of bone is comprised of OSTEOBLASTS; OSTEOCYTES; and OSTEOCLASTS, while FIBRILLAR COLLAGENS and hydroxyapatite crystals form the BONE MATRIX. Bone Tissue,Bone and Bone,Bone,Bones,Bones and Bone,Bones and Bone Tissue,Bony Apophyses,Bony Apophysis,Condyle,Apophyses, Bony,Apophysis, Bony,Bone Tissues,Condyles,Tissue, Bone,Tissues, Bone
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013723 Teratogens An agent that causes the production of physical defects in the developing embryo. Embryotoxins,Fetotoxins,Teratogen
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

M M Elmazar, and P R McElhatton, and F M Sullivan
January 1970, Folia morphologica,
M M Elmazar, and P R McElhatton, and F M Sullivan
September 1996, Convulsive therapy,
M M Elmazar, and P R McElhatton, and F M Sullivan
January 1973, Ginekologia polska,
M M Elmazar, and P R McElhatton, and F M Sullivan
January 1994, Natural toxins,
M M Elmazar, and P R McElhatton, and F M Sullivan
May 1997, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine],
M M Elmazar, and P R McElhatton, and F M Sullivan
March 1976, Zeitschrift fur Ernahrungswissenschaft,
M M Elmazar, and P R McElhatton, and F M Sullivan
April 1993, DTW. Deutsche tierarztliche Wochenschrift,
M M Elmazar, and P R McElhatton, and F M Sullivan
January 1979, Acta anatomica,
M M Elmazar, and P R McElhatton, and F M Sullivan
January 1972, Folia morphologica,
M M Elmazar, and P R McElhatton, and F M Sullivan
March 1984, Biulleten' eksperimental'noi biologii i meditsiny,
Copied contents to your clipboard!